Recombinant Human Anti-PD1 x Human Anti-TIM-3 Bispecific Antibody (scFv-Fc-scFv) (BSTF-H348)

Recombinant Anti-PD1 x Anti-TIM-3 Bispecific Antibody (scFv-Fc-scFv) is designed to be expressed as one chain, then assembled to a homodimer of bivalent scFv fragments and the Fc region of IgG. The anti-PD1 scFv is fused to the N-terminus of Fc via a hinge region while another anti-TIM-3 scFv is linked to the C-terminus of Fc. This scFv-Fc-scFv format has 2+2 antigen-binding valency by employing different scFv fragments. This BsAb can bind two receptors simultaneously and target unresponsive immune cells. It is designed for the research of Cancers therapy.

Datasheet INQUIRY

Specifications

Targets

PD1 & TIM-3

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Cancers

Targets

Target 1

PD1

Gene ID

5133

UniProt ID

Q15116

Alternative Names

PDCD1; programmed cell death 1; PD1; PD-1; CD279; SLEB2; hPD-1; hPD-l; hSLE1; programmed cell death protein 1; protein PD-1; systemic lupus erythematosus susceptibility 2

Target 2

TIM-3

Gene ID

84868

UniProt ID

Q8TDQ0

Alternative Names

TIM3; CD366; KIM-3; TIMD3; Tim-3; TIMD-3; HAVcr-2; T cell immunoglobulin and mucin domain 3; HAVCR2; hepatitis A virus cellular receptor 2

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-PD1 x Human Anti-TIM-3 Bispecific Antibody (scFv-Fc-scFv) (BSTF-H348). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-PD1 x Human Anti-TIM-3 Bispecific Antibody (scFv-Fc-scFv) (CAT#: BSTF-H348)

Specifications

Targets

Customer Reviews and Q&As